99 results on '"Casà A"'
Search Results
2. Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics
3. Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics
4. Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
5. Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
6. Switching from SB2 to PF-06438179/GP1111 and back in inflammatory bowel disease: “The Superswitchers”
7. Art and digital technologies to support resilience during the oncological journey: The Art4ART project
8. The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's disease
9. PO-1488 Brachytherapy plan reproducibility in gynecological cancer patients
10. Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
11. OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE
12. OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE
13. PO-1488 Brachytherapy plan reproducibility in gynecological cancer patients
14. OC.09.8 BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
15. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
16. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
17. The “PC-WIRED” study: atient entred volution of ebsites of talian adiotherapy epartments
18. PO-1292 Results of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer
19. PH-0445 Preliminary results of the Italian Retrospective Study on adjuvant radiotherapy for vulvar cancer
20. OC-0297 Preliminary results of the Italian Retrospective Study on exclusive radiotherapy for vulvar cancer
21. PO-1481 The “PC-WIRED” study: Patient Centred Evolution of Websites of Italian Radiotherapy Departments
22. PO-1721 Use of a bolus for skin cancer interventional radiotherapy in absence of model-based algorithms.
23. PO-1459 QUALIFIER:multiprofessionality quality assurance program for endovaginal interventional radiotherapy
24. A radiotherapy staff experience of gratitude during COVID-19 pandemic
25. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
26. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
27. OC.09.8 BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
28. PO-1721 Use of a bolus for skin cancer interventional radiotherapy in absence of model-based algorithms
29. PH-0445 Preliminary results of the Italian Retrospective Study on adjuvant radiotherapy for vulvar cancer
30. PO-1481 The 'PC-WIRED' study: Patient Centred Evolution of Websites of Italian Radiotherapy Departments
31. PO-1459 QUALIFIER:multiprofessionality quality assurance program for endovaginal interventional radiotherapy
32. OC-0297 Preliminary results of the Italian Retrospective Study on exclusive radiotherapy for vulvar cancer
33. Su453 BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN'S DISEASE PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
34. PO-0260 INTERBOARD: a dedicated tumor board to deal with personalized medicine in interventional oncology.
35. PO-0224 Dosimetric impact of a model based algorithm for skin cancer interventional radiotherapy
36. SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
37. PO-0224 Dosimetric impact of a model based algorithm for skin cancer interventional radiotherapy
38. PO-0260 INTERBOARD: a dedicated tumor board to deal with personalized medicine in interventional oncology
39. PH-0716: Radiomics pCR predictive model in rectal cancer: an intercontinental validation on real world data
40. OC-083: Predicting 2 years distant metastasis rate in rectal cancer: a MRI delta radiomics model
41. PO-1292 Results of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer
42. Su453 BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN'S DISEASE PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
43. PH-0716: Radiomics pCR predictive model in rectal cancer: an intercontinental validation on real world data
44. OC-083: Predicting 2 years distant metastasis rate in rectal cancer: a MRI delta radiomics model
45. PV-0310 A field strength independent MR radiomics model for pathological complete response in rectal cancer
46. EP-1468 Radiomics versus volume reduction for rectal cancer response prediction in hybrid MR guided RT
47. Delta Radiomics to Assess Tumor Behavior and Predict Distant Metastasis in Rectal Cancer
48. First detection of short-chain chlorinated paraffins (SCCPs) in humpback whales (Megaptera novaeangliae) foraging in Antarctic waters
49. EP-1468 Radiomics versus volume reduction for rectal cancer response prediction in hybrid MR guided RT
50. PV-0310 A field strength independent MR radiomics model for pathological complete response in rectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.